These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 22302269

  • 1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis.
    Salti GI, Ailabouni L, Undevia S.
    Ann Surg Oncol; 2012 May; 19(5):1410-5. PubMed ID: 22302269
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
    Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA.
    J Surg Oncol; 2013 Mar; 107(4):329-34. PubMed ID: 23386388
    [Abstract] [Full Text] [Related]

  • 4. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A.
    Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.
    In Vivo; 2010 Jan; 24(1):79-84. PubMed ID: 20133981
    [Abstract] [Full Text] [Related]

  • 9. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC, Yan TD, Morris DL.
    J Surg Oncol; 2009 Feb 01; 99(2):109-13. PubMed ID: 19016259
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG.
    Eur J Surg Oncol; 2012 Oct 01; 38(10):969-76. PubMed ID: 22763244
    [Abstract] [Full Text] [Related]

  • 11. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M.
    Eur J Cancer; 2013 Oct 01; 49(15):3140-8. PubMed ID: 23831335
    [Abstract] [Full Text] [Related]

  • 12. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.
    Ann Surg Oncol; 2012 Jul 01; 19(7):2186-94. PubMed ID: 22395983
    [Abstract] [Full Text] [Related]

  • 13. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N, Förtsch T, Aladashvili A, Hohenberger W, Croner RS.
    World J Surg Oncol; 2016 Feb 24; 14(1):42. PubMed ID: 26912149
    [Abstract] [Full Text] [Related]

  • 14. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Baratti D, Vaira M, Kusamura S, D'Amico S, Balestra MR, Cioppa T, Mingrone E, De Simone M, Deraco M.
    Eur J Surg Oncol; 2010 Nov 24; 36(11):1047-53. PubMed ID: 20832234
    [Abstract] [Full Text] [Related]

  • 15. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S.
    Ann Surg Oncol; 2006 Feb 24; 13(2):229-37. PubMed ID: 16444562
    [Abstract] [Full Text] [Related]

  • 16. Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy.
    Bhagwandin S, Naffouje S, Salti G.
    Ann Surg Oncol; 2015 Aug 24; 22(8):2573-7. PubMed ID: 25572680
    [Abstract] [Full Text] [Related]

  • 17. Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer.
    Ceelen WP, Van Nieuwenhove Y, Van Belle S, Denys H, Pattyn P.
    Ann Surg Oncol; 2012 Jul 24; 19(7):2352-9. PubMed ID: 20039210
    [Abstract] [Full Text] [Related]

  • 18. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb 24; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 19. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
    Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin RS, Griffin JR, Chase JL, Pisters PW, Pollock RE, Hunt KK.
    Ann Surg Oncol; 2007 Aug 24; 14(8):2309-18. PubMed ID: 17541691
    [Abstract] [Full Text] [Related]

  • 20. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.
    In Vivo; 2009 Aug 24; 23(4):639-44. PubMed ID: 19567401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.